An Update on Surgical Staging of Patients with Pancreatic Cancer
Abstract
Accurate staging of pancreatic adenocarcinoma is a crucial step in determining the appropriate therapeutic approach to pancreatic cancer and to maximizing life expectancy. Despite the availability of high-quality abdominal imaging, the use of multi-modality imaging and of diagnostic laparoscopy, a portion of surgically explored patients fail to undergo resection secondary to metastatic disease. This review is an update from the 2012 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium of new developments in the staging of localized pancreatic adenocarcinoma. (Abstracts #168, #177, and #212).
Downloads
References
American Cancer Society. Cancer Facts & Figures 2011. American Cancer Society: Atlanta, GA.
Bilimoria, K.Y. Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database. Cancer, 2007. 110(4): p. 738-44. [PMID 17580363]
Gudjonsson, B. Cancer of the Pancreas: Diagnostic Accuracy and Survival Statistics. Cancer, 1978. 42(5). [PMID 363259]
Freeny, P.C. Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. The American journal of surgery, 1993. 165(5): p. 600-6. [PMID 8488945]
Fuhrman, G.M. Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. The American journal of surgery, 1994. 167(1): p. 104-11; discussion 111-3 [PMID 7906097]
Stefanidis, D. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Annals of oncology, 2006. 17(2): p. 189-99. [PMID 16236756]
Kauhanen, S.P. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Annals of surgery, 2009. 250(6): p. 957-63. [PMID 19687736]
Diederichs, C.G. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas, 2000. 20(2): p. 109-16. [PMID 10707924]
Nishiyama, Y. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Annals of nuclear medicine, 2005. 19(6): p. 491-497. [PMID 16248386]
Jimenez, R.E. Impact of laparoscopic staging in the treatment of pancreatic cancer. Archives of surgery (Chicago. 1960), 2000. 135(4): p. 409-14; discussion 414-5. [PMID 10768705]
Santoro, P. Is laparoscopy still needed for staging resectable pancreatic cancer? Journal of Clinical Oncology, 2012. 30(suppl 4): p. abstract 168
Conlon, K.C. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Annals of surgery, 1996. 223(2): p. 134-40. [PMID 8597506]
Warshaw, A.L. Implications of peritoneal cytology for staging of early pancreatic cancer. The American journal of surgery, 1991. 161(1): p. 26-9; discussion 29-30. [PMID 1824810]
Fernández-del Castillo, C.L. Pancreatic cancer. Laparoscopic staging and peritoneal cytology. Surgical Oncology Clinics of North America, 1998. 7(1): p. 135-42. [PMID 9443991]
Liu, R.C. Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surgical endoscopy, 2005. 19(5): p. 638-42. [PMID 15776215]
Nieveen van Dijkum, E.J. Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful? Annals of surgery, 1998. 228(6): p. 728-33. [PMID 9860470]
Chen, K. Revisiting the prognostic significance of positive peritoneal cytology in pancreatic cancer. Journal of Clinical Oncology, 2012. 30(suppl 4): p. abstract 177]
D'Hallewin, M.-A., L. Bezdetnaya, and F. Guillemin. Fluorescence Detection of Bladder Cancer: A Review. European Urology, 2002. 42(5): p. 417-425. [PMID 12429148]
George, P.J. Fluorescence bronchoscopy for the early detection of lung cancer. Thorax, 1999. 54(2): p. 180-3
Hoda, M.R. Surgical outcomes of fluorescence-guided laparoscopic partial nephrectomy using 5-aminolevulinic acid-induced protoporphyrin IX. The Journal of surgical research, 2009. 154(2): p. 220-5. [PMID 19375717]
Löning, M. Laparoscopic fluorescence detection of ovarian carcinoma metastases using 5-aminolevulinic acid-induced protoporphyrin IX. Cancer, 2004. 100(8): p. 1650-6. [PMID 15073853]
Gahlen, J. Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies. Annals of surgery, 2002. 235(2): p. 252-60. [PMID 11807366]
Zöpf, T. Improved preoperative tumor staging by 5-aminolevulinic acid induced fluorescence laparoscopy. Gastrointestinal endoscopy, 2005. 62(5): p. 763-7. [PMID 16246693]
Metildi, C. Use of high-resolution fluorescence laparoscopy with fluorophore-conjugated tumor-specific antobodies for the detection of pancreatic cancer metastases invisible with standard laparoscopy. Journal of Clinical Oncology, 2012. 30(suppl 4): p. abstract 212
Hoffman, R.M. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nature reviews. Cancer, 2005. 5(10): p. 796-806. [PMID 16195751]
Kishimoto, H. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation. PNAS : Proceedings of the National Academy of Sciences, 2009. 106(34): p. 14514-7. [PMID 19706537]
Tran Cao, H.S. Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model. Surgical endoscopy, 2011. 25(1): p. 48-54. [PMID 20533064]
Clinical Outcomes of Surgical Therapy, S. A comparison of laparoscopically assisted and open colectomy for colon cancer. The New England journal of medicine, 2004. 350(20): p. 2050-9. [PMID 15141043]
Lacy, A.M. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. The Lancet (British edition), 2002. 359(9325): p. 2224-9. [PMID 12103285]
Urbach, D.R., L.L. Swanstrom, and P.D. Hansen. The Effect of Laparoscopy on Survival in Pancreatic Cancer. Arch Surg, 2002. 137(2): p. 191-199. [PMID 11822959]
Rumstadt, B. The role of laparoscopy in the preoperative staging of pancreatic carcinoma. Journal of Gastrointestinal Surgery, 1997. 1(3): p. 245-50. [PMID 9834354]
Friess, H. The role of diagnostic laparoscopy in pancreatic and periampullary malignancies. Journal of the American College of Surgeons, 1998. 186(6): p. 675-82. [PMID 9632157]
Holzman, M.D. The role of laparoscopy in the management of suspected pancreatic and periampullary malignancies. Journal of Gastrointestinal Surgery, 1997. 1(3): p. 236-43; discussion 243-4. [PMID 9834353]
Andrén-Sandberg, A. Computed tomography and laparoscopy in the assessment of the patient with pancreatic cancer. Journal of the American College of Surgeons, 1998. 186(1): p. 35-40. [PMID 9449598]
Obertop, H. Essentials in biliopancreatic staging: a decision analysis. Annals of oncology, 1999. 10 Suppl 4(4): p. 150-2. [PMID 10436810]
Copyright (c) 2014 Megan Winner, John D Allendorf, Muhammad Wasif Saif
This work is licensed under a Creative Commons Attribution 4.0 International License.
As a member of Publisher International Linking Association, PILA, iMedPub Group’s JOP follows the Creative Commons Attribution License and Scholars Open Access publishing policies. Journal of the Pancreas is the Council Contributor Member of Council of Science Editors (CSE) and following the CSE slogan Education, Ethics, and Evidence for Editors.